Literature DB >> 26112831

Treatment outcomes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: A single-institution study.

Ji Heui Kim1, Yoon Se Lee1, Yoo-Sam Chung1, Yong Ju Jang1, Sung-Bae Kim2, Sang-Wook Lee3, Bong-Jae Lee1.   

Abstract

CONCLUSIONS: CCRT is a potential treatment option for locally advanced sinonasal SCC in terms of organ preservation.
OBJECTIVES: Concurrent chemoradiotherapy (CCRT) is increasingly used for patients with advanced head and neck cancer to preserve organ function and improve survival. In the present study, treatment outcomes were compared between surgery and post-operative radiotherapy (PORT) and CCRT in patients with locally advanced sinonasal squamous cell carcinoma (SCC).
METHODS: The records of 30 patients with non-metastatic stage III and IV sinonasal SCC were retrospectively reviewed. Fifteen patients were treated with CCRT and 15 patients underwent PORT.
RESULTS: The locoregional recurrence-free, distant metastasis-free, disease-free, disease-specific, and overall survival rates did not differ between PORT and CCRT groups. In addition, there were no significant differences in incidence rates of acute and chronic toxicities between the two groups.

Entities:  

Keywords:  Concurrent chemoradiotherapy; paranasal sinus; radiotherapy; squamous cell carcinoma; surgery

Mesh:

Substances:

Year:  2015        PMID: 26112831     DOI: 10.3109/00016489.2015.1061697

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

Review 1.  Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment.

Authors:  Mayur D Mody; Nabil F Saba
Journal:  Curr Treat Options Oncol       Date:  2020-01-16

2.  Treatment Outcomes of Sinonasal Malignancies Involving the Orbit.

Authors:  Chul Ho Shin; Ho Jun Lee; Yoo-Sam Chung; Ji Heui Kim
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-29

3.  Organ preservation with neoadjuvant chemoradiation in patients with orbit invasive sinonasal cancer otherwise requiring exenteration.

Authors:  Mark J Amsbaugh; Mehran Yusuf; Craig Silverman; Jeffrey Bumpous; Cesar A Perez; Keven Potts; Paul Tennant; Rebecca Redman; Neal Dunlap
Journal:  Radiat Oncol J       Date:  2016-09-05

4.  Preliminary Study of Chemoradiotherapy Using Modified Docetaxel, Cis-diaminodichloroplatinum, and 5-Fluorouracil for Sinonasal Squamous Cell Carcinoma.

Authors:  Katsunori Katagiri; Kiyoto Shiga; Daisuke Saito; Shin-Ichi Oikawa; Aya Ikeda; Kodai Tsuchida; Jun Miyaguchi; Takahiro Kusaka; Takumi Sariishi; Hisanori Ariga
Journal:  OTO Open       Date:  2021-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.